Spin of the Day: July 10, 2008

July 10, 2008

FTC Considers Dropping Its Tar and Nicotine Measuring Method

Topics: |

FTC smoking machineFTC smoking machineThe U.S. Federal Trade Commission (FTC) is considering stopping use of the "FTC Method" to determine the amounts of tar and nicotine in cigarettes, a test that tobacco companies have touted on cigarette packs for over 40 years and have long used to market "light," "ultralight" and "low tar" cigarettes. The FTC started using the "Cambridge Filter Method" to test for tar and nicotine in 1966, when public health authorities believed that reducing the amount of tar in cigarettes would reduce the risk of lung cancer. In recent years, evidence has proven the test meaningless because it was found that smokers "compensate," or adjust how they smoke, to get the amount of nicotine they need from a cigarette, regardless of nicotine content. Senators Frank Lautenberg (D-New Jersey) and Olympia Snowe (R-Maine) have introduced a bill to stop cigarette companies from using the "FTC Method" to measure tar and nicotine. "For years, Big Tobacco has relied on the FTC's flawed testing method to mislead smokers into thinking these ['light' and 'low tar'] cigarettes deliver less tar and nicotine...In reality, some so-called 'light' and 'low tar' cigarettes can actually be more harmful for smokers," Lautenberg said.


Drug Companies Move to Regulate Themselves, Before Anyone Else Does

The Pharmaceutical Research and Manufacturers of America (PhRMA) has announced a ban on giving branded items to doctors. The pens, notepads, mugs and other gifts are ubiquitous in medical offices. Some, like Senator Herb Kohl, think it is a step in the right direction. "We've been pushing to see reforms like this for some time now. Consumers will undoubtedly be the beneficiaries of these industry changes." But the voluntary code does nothing to stem the more egregious ways that drug companies influence doctors, including speaking fees and lavish "educational" events. Kohl has co-sponsored a bill to require drug and medical device companies to publicly disclose payments to doctors of $500 or more, but does not ban them. Industry watchdogs are not convinced. One complained that "It strikes me as an attempt to persuade people against doing anything that's serious." The industry’s new policy, the Code on Interactions with Health Care Professionals, "will ask the chief executives of large drug makers to certify in writing that 'they have policies and procedures in place to foster compliance with the code.'" But because it is voluntary, there will be no accountability or regulation. Former U.S. Representative Billy Tauzin now heads PhRMA. Tauzin said, "This updated code fortifies our companies' commitment to ensure their medicines are marketed in a manner that benefits patients and enhances the practice of medicine." CMD staffer Anne Landman recently wrote about the perils of letting industries self-regulate.


A Match Made In Political PR Heaven

Karen Hughes and Mark PennKaren Hughes and Mark PennFormer undersecretary of state for public diplomacy and public affairs and longtime George Bush advisor and confidante Karen Hughes has taken a position with PR giant Burson Marsteller. She will be working closely with former Hillary Clinton campaign guru Mark Penn. As CMD previously reported, Penn's dual role with the Clinton campaign and B-M was problematic. He was found to be working for Colombia on a free trade deal that Clinton opposed. B-M also works for anti-union clients, while Clinton was counting on labor's support. For her part, Hughes was unable to repair a badly broken U.S. image abroad. Hiring Hughes is part of a larger effort by Penn to increase B-M's "reach and expertise." Summing up the partnership, Penn said "Karen and I have had so many of the same experiences in the White House and campaigns, and have worked around the world. But we agreed that we won't let politics interfere in our business."


Europe Backpedals on Biofuels

The European Union (EU) has drastically changed its course for the future of biofuels. Until this week, the EU planned to be the world leader in using biofuels as an alternative to petroleum-based fuel, aiming for 10% of transportation fuels to be derived from biofuels by 2020. "But the allure has dimmed amid growing evidence that the kind of targets proposed by the EU are contributing to deforestation and helping force up food prices." In the overall energy landscape, the EU currently produces 8.5% of its energy from renewable sources. The goal was to increase that to 20% by 2020, but biofuels were a large part of that equation. '"I think when we will look back we will say this was the beginning of a turning point for Europe on biofuels,' said Juan Delgado, a research fellow specializing in energy and climate change expert at Breugel, a research organization in Brussels. 'It will be very difficult now for Europe to stick by its targets.'" In a related story, The Guardian newspaper revealed last week that a secret World Bank report found that "biofuels have forced global food prices up by 75% - far more than previously estimated." The U.S. government has said that biofuels are only responsible for a 3% increase in food costs worldwide.